○Takeshi Yanagihara1, Ayako Yokomizo2, Takashi Kawaguchi3, Kazuhiro Shimomura4, Hirotoshi Iihara5, Mistuhiro Sugawara6, Marina Mitsui7, Hiroshi Ishikawa8, Shuichi Nawata9, Ayako Tsuboya10, Keisuke Mishima11, Kei Morikawa12, Shunsuke Oyamada13, Kazunori Honda14, Hiroko Yukawa1, Yasushi Ohno15, Chikatoshi Katada16, Naoya Hida17, Takuhiro Yamaguchi18, Takako Nakajima19 (1.Department of Medical Oncology, Yokohama Rosai Hospital, 2.Department of Pharmacy, St. Marianna University School of Medicine Hospital, 3.Department of Practical Pharmacy, Tokyo University of Pharmacy and Life Sciences, 4.Department of Pharmacy, Aichi Cancer Center Hospital, 5.Department of Pharmacy, Gifu University Hospital, 6.Division of Clinical Pharmacy, Kitasato University School of Pharmacy, 7.Department of Pharmacy, St. Marianna University School of Medicine Yokohama City Seibu Hospital, 8.Department of Pharmacy, Shizuoka Cancer Center, 9.Department of Pharmacy, Showa University Hospital, 10.Department of Pharmacy, Kawasaki Municipal Tama Hospital, 11.Department of Digestive Surgery, Nippon Medical School Musashikosugi Hospital, 12.Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, 13.Department of Biostatistics, JORTC Data Center, 14.Department of Clinical Oncology, Aichi Cancer Center Hospital, 15.Department of Cardiology and Respiratory Medicine, Gifu University Graduate School of Medicine, 16.Department of Gastroenterology, Kitasato University School of Medicine, 17.Department of Pulmonary Medicine. St. Marianna University School of Medicine Yokohama City Seibu Hospital, 18.Biostatistics, Tohoku University Graduate School of Medicine, 19.Department of Early Clinical Development, Graduate School of Medicine, Kyoto University Hospital)
Session information
Mini-Oral Session
[MO36] Mini-Oral Session 36 Palliative Care / Symptom Management 2
Sat. Feb 19, 2022 3:40 PM - 4:30 PM Room 6 (Room D, 1F, Kyoto International Conference Center)
Chair:Toshiyuki Sawa(Cancer Center, Gifu Municipal Hospital),Takuo Shibayama(Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center)
○Kenichi Inoue1, Kazuo Matsuura2, Junji Tsurutani3, Yuko Tanabe4, Tetsuhiko Taira5, Kaoru Kubota6, Tomohide Tamura7, Toshiaki Saeki2 (1.Division of Breast Oncology, Saitama Cancer Center, 2.Department of Breast Oncology, Saitama Medical University International Medical Center., 3.Advanced Cancer Translational Research Institute, Showa University, 4.Department of Medical Oncology, Toranomon Hospital, 5.Department of Medical Oncology, Sagara Hospital, 6.Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 7.Thoracic Center, St. Luke's International Hospital)
○Koki Hashimoto1, Toshinobu Hayashi2, Mototsugu Shimokawa3, Reiko Matsui4, Maki Todo5, Shinya Tamaki6, Tomohiko Harada7, Motohiko Sano8, Yasumasa Koike9, Yukiyoshi Fujita10, Hirotoshi Iihara11, Hironobu Hashimoto12, Hiroko Minatogawa13, Masayo Komoda14, Masakazu Abe15, Naoki Inui16, Kenji Okita17, Junichi Nishimura18, Nobuyuki Yamamoto19, Mitsue Saito20 (1.Department of Pharmacy, Japanese Foundation for Cancer Research, Cancer Institute Hospital, 2.Faculty of Pharmaceutical Sciences, Fukuoka University, 3.Department of Biostatistics, Yamaguchi University, 4.Department of Pharmacy, National Cancer Center Hospital East, 5.Department of Pharmacy, Saitama Medical University International Medical Center, 6.Department of Pharmacy, KKR Sapporo Medical Center, 7.Department of Pharmacy, Kanagawa Cancer Center, 8.Division of Applied Pharmaceutical Education and Research, Hoshi University, 9.Department of Pharmacy, National Hospital Organization Shikoku Cancer Center, 10.Division of Pharmacy, Gunma Prefectural Cancer Center, 11.Department of Pharmacy, Gifu University Hospital, 12.Department of Pharmacy, National Cancer Center Hospital, 13.Department of Pharmacy, St. Marianna University School of Medicine Hospital, 14.Department of Pharmacy, Chiba-Nishi General Hospital, 15.Department of obstetrics and gynecology, Hamamatsu University School of Medicine, 16.Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, 17.Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, 18.Department of Gastroenterological Surgery, Osaka International Cancer Institute, 19.Internal Medicine III, Wakayama Medical University, 20.Department of Breast Oncology, Juntendo University Hospital)
○Kei Muro1, Kentaro Yamazaki2, Keun-Wook Lee3, Kensei Yamaguchi4, Naotoshi Sugimoto5, Sang-Cheul Oh6, Taroh Satoh7, Sung Yong Oh8, Yoichiro Yoshida9, Dae Young Zang10, Ichiro Takemasa11, Eiji Oki12, Sang-Hee Cho13, Jaw-Yuan Wang14, Hiroshi Matsuoka15, Anders Persson16, Jacques Näsström16, Yusuke Sonehara17, Fumiko Nagahama17, Takeshi Kato18 (1.Aichi Cancer Center Hospital, 2.Shizuoka Cancer Center, 3.Seoul National University Bundang Hospital, Republic of Korea, 4.Cancer Institute Hospital of Japanese Foundation for Cancer Research, 5.Osaka International Cancer Institute, 6.Korea University Guro Hospital, Republic of Korea, 7.Osaka University Hospital, 8.Dong-A University Hospital, Republic of Korea, 9.Fukuoka University Hospital, 10.Hallym University Sacred Heart Hospital, Republic of Korea, 11.Sapporo Medical University Hospital, 12.Kyushu University Hospital, 13.Chonnam National University Hwasun Hospital, Republic of Korea, 14.Kaohsiung Medical University Chung-Ho Memorial Hospital, Taiwan, 15.Fujita Health University Hospital, 16.Egetis Therapeutics AB, Sweden, 17.Solasia Pharma K.K., Japan, 18.National Hospital Organization Osaka National Hospital,)
○Takanori Miyoshi1, Toshinobu Hayashi2, Uoi Miyuki3, Fuyuki Omura1, Kyouichi Tsumagari4, Sachi Maesaki5, Chiaki Yokota6 (1.Department of Pharmacy, National Hospital Organization Kyushu Medical Center, 2.Department of Pharmaceutical and Health Care Management, Faculty of Pharmaceutical Sciences, Fukuoka University, 3.Department of Pharmacy, National Hospital Organization Kyushu Cancer Center, 4.Division of Pharmaceutical Services, National Hospital Organization Okinawa National Hospital, 5.Department of Pharmacy, National Hospital Organization Kumamoto Saishun Medical Center, 6.Department of Pharmacy, National Hospital Organization Nagasaki Medical Center)
○Yuko Tanabe1, Hiroko Masuda2, Koji Matsumoto3, Akihiko Shimomura4, Mihoko Doi5, Yasuo Miyoshi6, Masato Takahashi7, Yasuaki Sagara8, Shinya Tokunaga9, Tsutomu Iwasa10, Naoki Niikura11, Kenichi Yoshimura13, Toshimi Takano14, Junji Tsurutani14 (1.Department of Medical Oncology, Toranomon Hospital, 2.Department of Breast Surgical Oncology, Showa University, 3.Medical Oncology Division, Hyogo Cancer Center, 4.Department of Breast and Medical Oncology, 5.Division of Clinical Oncology, Hiroshima Prefectural Hospital, 6.Division of Breast and Endocrine, Department of Surgery, Cancer Center, Hyogo College of Medicine, 7.Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, 8.Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, 9.Department of Medical Oncology, Osaka City General Hospital, 10.Department of Medical Oncology, Kindai University Hospital, 11.Department of Breast Oncology, Tokai University School of Medicine, 12.Center for Integrated Medical Research, Hiroshima University, 13.Department of Breast Medical Oncology The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 14.Advanced Cancer Translational Research Institute, Showa University)